Based on recent data, Abbott Laboratories (ABT) shows an Average True Range (ATR) of 2.26 and an Enterprise Value of 192.75B. Its average trading volume over the past 3 months is 10.86M, indicating liquidity. These fundamental metrics provide insight into ABT's underlying financial health and market activity.
| ATR | 2.26 |
| Enterprise Value | 192.75B |
| Avg Vol (3 Months) | 10.86M |
| Avg Vol (10 Days) | 7.47M |
Abbott Laboratories (ABT) technical indicators as of September 10, 2026: the SMA 20 is 4.07%, SMA 50 at -1.48%, and SMA 200 at -8.79%. The RSI 14 value is 56.54, suggesting its current momentum. These technical analysis signals help assess ABT's price trends and potential future movements.
| SMA 20 | 4.07% |
| SMA 50 | -1.48% |
| SMA 200 | -8.79% |
| RSI 14 | 56.54 |
Abbott Laboratories (ABT) stock performance overview as of September 10, 2026: The 52-week high is $137.49 (currently -17.69% below), and the 52-week low is $81.97 (currently 10.42% above). Over the past year, ABT's performance is 6.35%, compared to the S&P 500's 1.11% change.
| 52-Week High | 137.49 |
| 52-Week High Chg | -17.69% |
| 52-Week Low | 81.97 |
| 52-Week Low Chg | +10.42% |
| S&P 500 52-Week Chg | 1.11% |
According to market data, Abbott Laboratories (ABT) stock's recent performance metrics show that over the last month, ABT is -4.4%, with a Year-to-Date (YTD) performance of -3.31%. Over the past year, the stock has seen a 6.35% change. These figures summarize ABT's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 112.2 | 117.34 | 117.34 | 117.34 | 137.49 | 129.46 |
| Low | 104.78 | 104.78 | 87.07 | 81.97 | 81.97 | 81.97 |
| Performance | -2.81% | -4.40% | -5.76% | -2.64% | +6.35% | -3.31% |
According to current financial data, ABT stock's P/E (TTM) ratio is 33.34, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.25. Key valuation ratios for ABT, including P/S (3.85), P/B (3.54), and P/FCF (20.58), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ABT | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 33.34 | -1.25 | -14.5 | 32.59 |
| P/S (TTM) | 3.85 | 3.71 | 16 | 5.98 |
| P/B (TTM) | 3.54 | 1.26 | 2.62 | 5.47 |
| P/FCF (TTM) | 20.58 | -1.88 | -0.7 | 28.11 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep